Marathon Petroleum Corp vs Revolution Medicines Inc. Common Stock — how do they compare? Marathon Petroleum Corp trades at $455.51 (market cap $130.12B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Marathon Petroleum Corp is far larger — about 3.2× Revolution Medicines Inc. Common Stock's market cap, and Marathon Petroleum Corp pays a 0.86% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Petroleum Corp for 54 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| MPC | RVMD | |
|---|---|---|
Market Cap | $130.12B | $40.32B |
Volume | 2,749,647 | 4,855,734 |
Sector | Energy | Health |
52-Week High | $463.34 | $221.15 |
52-Week Low | $162.63 | $47.50 |
Typical Hold Time | 54 Days | 0 Days |
Enterprise Value | $156.64B | $37.02B |
Dividend Yield | 0.86% | — |
Signals from Pluang's Aura AI — not financial advice
Marathon Petroleum (MPC) trades at $461.79, up 4.42% today, showing strong momentum with three consecutive earnings beats. Technical indicators signal bullish momentum with the stock trading near resistance at $463. Fundamentally, the company maintains solid profitability with 5.57% net margin and 47.9% ROE, though revenue has declined from $177.5B in 2022 to $132.7B in 2025. Analyst consensus remains strongly bullish with 25 buy ratings and a $420.30 price target.
MPC presents a compelling value opportunity with attractive valuation multiples (P/E 16.07, P/S 0.9) and strong earnings momentum. Key risks include potential diesel export restrictions, declining revenue trends, and elevated debt levels. The stock's current price above consensus target suggests near-term caution despite positive technical and fundamental momentum.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →